Older men with early-stage prostate cancer are not taking a big risk if they keep an eye on the disease instead of treating it right away, according to a study. Otis Brawley, chief medical officer of the American Cancer Society, said the findings were important because it may persuade some doctors that they are overtreating this disease.
Trending:
Study: Older men with prostate cancer can delay treatment